Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Ory

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Plos One|January 27, 2018
Implication of molecular vascular smooth muscle cell heterogeneity among arterial beds in arterial calcificationOlivier Espitia, Mathias Chatelais, Marja Steenman, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 20, 2020
MicroRNA-17-5p Reduces Inflammation and Bone Erosions in Mice With Collagen-Induced Arthritis and Directly Targets the JAK/STAT Pathway in Rheumatoid Arthritis Fibroblast-like SynoviocytesAurélie Najm, François-Marie Masson, Pauline Preuss, et al.
Oncotarget|December 6, 2018
Loss of miR-198 and -206 during primary tumor progression enables metastatic dissemination in human osteosarcomaSteven Georges, Lidia Rodriguez Calleja, Camille Jacques, et al.
Cancer Research|October 26, 2010
Zoledronic acid potentiates mTOR inhibition and abolishes the resistance of osteosarcoma cells to RAD001 (Everolimus): pivotal role of the prenylation processGatien Moriceau, Benjamin Ory, Laura Mitrofan, et al.
Cells|September 28, 2021
Overexpression of the Ubiquitin Specific Proteases USP43, USP41, USP27x and USP6 in Osteosarcoma Cell Lines: Inhibition of Osteosarcoma Tumor Growth and Lung Metastasis Development by the USP Antagonist PR619Mélanie Lavaud, Mathilde Mullard, Robel Tesfaye, et al.
Bone|November 7, 2016
Inhibition of BET proteins and epigenetic signaling as a potential treatment for osteoporosisMarc Baud'huin, François Lamoureux, Camille Jacques, et al.
Ebiomedicine|March 11, 2020
TH1579, MTH1 inhibitor, delays tumour growth and inhibits metastases development in osteosarcoma modelBrice Moukengue, Hannah K Brown, Céline Charrier, et al.
Cell Death Discovery|February 5, 2026
Activating GCN2 and subsequently the Unfolded Protein Response with the small oral molecule NXP800 delays tumor growth in osteosarcomaEmma Racineau, Morgane Lallier, Anaïs Postec, et al.
Cancers|November 24, 2020
Sonic Hedgehog Signature in Pediatric Primary Bone Tumors: Effects of the GLI Antagonist GANT61 on Ewing's Sarcoma Tumor GrowthMathilde Mullard, Marie Cadé, Sarah Morice, et al.
Molecular Cancer|February 27, 2020
Cytosine methylation of mature microRNAs inhibits their functions and is associated with poor prognosis in glioblastoma multiformeMathilde Cheray, Amandine Etcheverry, Camille Jacques, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Plos One|January 27, 2018
Implication of molecular vascular smooth muscle cell heterogeneity among arterial beds in arterial calcificationOlivier Espitia, Mathias Chatelais, Marja Steenman, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 20, 2020
MicroRNA-17-5p Reduces Inflammation and Bone Erosions in Mice With Collagen-Induced Arthritis and Directly Targets the JAK/STAT Pathway in Rheumatoid Arthritis Fibroblast-like SynoviocytesAurélie Najm, François-Marie Masson, Pauline Preuss, et al.
Oncotarget|December 6, 2018
Loss of miR-198 and -206 during primary tumor progression enables metastatic dissemination in human osteosarcomaSteven Georges, Lidia Rodriguez Calleja, Camille Jacques, et al.
Cancer Research|October 26, 2010
Zoledronic acid potentiates mTOR inhibition and abolishes the resistance of osteosarcoma cells to RAD001 (Everolimus): pivotal role of the prenylation processGatien Moriceau, Benjamin Ory, Laura Mitrofan, et al.
Cells|September 28, 2021
Overexpression of the Ubiquitin Specific Proteases USP43, USP41, USP27x and USP6 in Osteosarcoma Cell Lines: Inhibition of Osteosarcoma Tumor Growth and Lung Metastasis Development by the USP Antagonist PR619Mélanie Lavaud, Mathilde Mullard, Robel Tesfaye, et al.
Bone|November 7, 2016
Inhibition of BET proteins and epigenetic signaling as a potential treatment for osteoporosisMarc Baud'huin, François Lamoureux, Camille Jacques, et al.
Ebiomedicine|March 11, 2020
TH1579, MTH1 inhibitor, delays tumour growth and inhibits metastases development in osteosarcoma modelBrice Moukengue, Hannah K Brown, Céline Charrier, et al.
Cell Death Discovery|February 5, 2026
Activating GCN2 and subsequently the Unfolded Protein Response with the small oral molecule NXP800 delays tumor growth in osteosarcomaEmma Racineau, Morgane Lallier, Anaïs Postec, et al.
Cancers|November 24, 2020
Sonic Hedgehog Signature in Pediatric Primary Bone Tumors: Effects of the GLI Antagonist GANT61 on Ewing's Sarcoma Tumor GrowthMathilde Mullard, Marie Cadé, Sarah Morice, et al.
Molecular Cancer|February 27, 2020
Cytosine methylation of mature microRNAs inhibits their functions and is associated with poor prognosis in glioblastoma multiformeMathilde Cheray, Amandine Etcheverry, Camille Jacques, et al.
Pageof 6